Mitsui Chemicals — Developing Dental Materials M&A as a Third Growth Pillar
- Acquisition of Ultradent in 2026 to establish a US dental materials platform and expand oral-care reach.
- L&HC FY30 sales target ¥86 billion with ROS 17% (FY28 target ¥67 billion, ROS 15%).
- Whitening market CAGR projected at 9%, with Ultradent global top in whitening and Kulzer strong in restorative.
- FY25–28 cash plan: net cash inflow ≈ ¥800bn and growth investments ≈ ¥900bn; ROIC target ≥7% and ROE ≥10% by FY28.
Strategy and portfolio transformation
Under Vision 2030 Mitsui Chemicals will actively invest (organic and M&A) to transform its portfolio from Mobility-weighted to three balanced specialty domains: Life & Healthcare (L&HC), Mobility and ICT. The plan calls for restructuring underperforming businesses and bolstering downstream operations, with decisive actions on affiliates to be taken by end of FY26.
Financial targets and cash allocation
The group targets L&HC and ICT to reach global specialty status within 2–3 years and a 25% ROS for specialty-chemicals domains by FY28. FY28 targets include ROIC ≥7%, ROE ≥10%, operating income before special items ¥200bn and net income ≥¥110bn. Cash-flow plan (FY25–28) projects net business inflow ≈¥800bn and growth investments ≈¥900bn, keeping net D/E ≤0.8.
Ultradent acquisition and synergies
Acquiring Ultradent (2026) creates a dental materials platform in the US. Expected non-financial synergies: customer- and data-driven AI solutions, fast execution, in-house processing/production technology, and complementary Mitsui capabilities in materials, applications and IT/data infrastructure. PMI will be executed with local teams and Kulzer participation.
Oral-care market positioning
Mitsui plans one-stop dental care combining Ultradent (whitening leader), Kulzer (restorative/denture strengths) and Mitsui materials. L&HC sales targets: FY25 ¥34.2bn (ROS 13%), FY28 ¥67bn (ROS 15%), FY30 ¥86bn (ROS 17%). Whitening is highlighted with a 9% CAGR; regional sales mix shifts to greater Americas exposure after the acquisition.
Source: Mitsui Chemicals
